Research Article
Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis
Table 2
Parameters of liver function and fibrosis in examined patients.
| | Parameters | Range of activity | Mean activity | Number of patients with abnormality |
| | Aspartate aminotransferase (AST) | 10.0-151.0 (U/l) | 44.025 (U/l) | 31/79 (39.2%) | | Gamma-glutamyltranspeptidase (GTP) | 6-314 (U/l) | 47.3 (U/l) | 21/79 (26.6%) | | Alanine aminotransferase (ALT) | 9.0-142.0 (U/l) | 34.57 (U/l) | 19/79 (24.1%) | | Alkaline phosphatase (AF) | 111-697 (U/l) | 343.9 (U/l) | 11/79 (13.9%) | | Bile acids | 1.1-86 (μmol/l) | 15.6 (μmol/l) | 8/79 (10.1%) | | Total bilirubin | 1.6-28.4 (μmol/l) | 9.35 (μmol/l) | 6/79 (7.6%) | | Alpha2-macroglobulin (g/l) | 1.8-4.76 | 3.50 | 28/79 (35.4%) | | Apolipoprotein A1 (g/l) | 0.57- 2.03 | 1.36 | 12/79 (15.2%) | | Haptoglobin (g/l) | 0.03-3.54 | 1.25 | 19/79 (24.05%) |
|
|
